I Kline

902 total citations
60 papers, 702 citations indexed

About

I Kline is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, I Kline has authored 60 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Public Health, Environmental and Occupational Health and 13 papers in Genetics. Recurrent topics in I Kline's work include Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and T-cell and Retrovirus Studies (5 papers). I Kline is often cited by papers focused on Acute Lymphoblastic Leukemia research (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and T-cell and Retrovirus Studies (5 papers). I Kline collaborates with scholars based in United States, Malaysia and India. I Kline's co-authors include John M. Venditti, A Goldin, Nathan Mantel, Joseph Leighton, Abraham Goldin, V.S. Waravdekar, Alphonse E. Sirica, Richard Woodman, Morris Belkin and Michael Belkin and has published in prestigious journals such as Nature, Science and JNCI Journal of the National Cancer Institute.

In The Last Decade

I Kline

58 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Kline United States 17 266 242 85 83 81 60 702
I Wodinsky United States 15 331 1.2× 492 2.0× 74 0.9× 90 1.1× 90 1.1× 69 979
Montgomery Ja United States 11 234 0.9× 282 1.2× 58 0.7× 35 0.4× 86 1.1× 18 685
Trader Mw United States 12 402 1.5× 290 1.2× 75 0.9× 48 0.6× 152 1.9× 16 718
J.R. Bertino United States 16 221 0.8× 462 1.9× 105 1.2× 191 2.3× 75 0.9× 28 925
Carl G. Schmidt Germany 13 265 1.0× 349 1.4× 142 1.7× 98 1.2× 84 1.0× 33 798
Griswold Dp United States 14 496 1.9× 338 1.4× 62 0.7× 54 0.7× 187 2.3× 19 885
Corbett Th 8 377 1.4× 267 1.1× 41 0.5× 34 0.4× 143 1.8× 8 652
Skipper He United States 18 512 1.9× 446 1.8× 155 1.8× 122 1.5× 161 2.0× 37 1.2k
Laster Wr United States 18 574 2.2× 433 1.8× 116 1.4× 84 1.0× 242 3.0× 28 1.2k
Von Hoff United States 16 540 2.0× 295 1.2× 121 1.4× 72 0.9× 171 2.1× 39 1.1k

Countries citing papers authored by I Kline

Since Specialization
Citations

This map shows the geographic impact of I Kline's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Kline with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Kline more than expected).

Fields of papers citing papers by I Kline

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Kline. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Kline. The network helps show where I Kline may publish in the future.

Co-authorship network of co-authors of I Kline

This figure shows the co-authorship network connecting the top 25 collaborators of I Kline. A scholar is included among the top collaborators of I Kline based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Kline. I Kline is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, Forrest, A Rahman, A. Bennett Jenson, I Kline, & P. Schein. (1983). Toxicity evaluation of doxorubicin entrapped in cardiolipin liposomes in mice. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 260. 3 indexed citations
2.
Guarino, Anthony M., Marcel Rozencweig, I Kline, et al.. (1979). Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents.. PubMed. 39(6 Pt 1). 2204–10. 19 indexed citations
3.
Kline, I. (1974). Potentially useful combinations of chemotherapy detected in mouse tumor systems.. PubMed. 4(1). 33–43. 6 indexed citations
5.
Kline, I, et al.. (1972). Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.. PubMed. 56(4). 483–92. 3 indexed citations
6.
Field, Ruth B., et al.. (1972). THE EFFECT OF PHENOBARBITAL OR 2-DIETHYLAMINOETHYL-2,2-DIPHENYLVALERATE ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO. Journal of Pharmacology and Experimental Therapeutics. 180(2). 475–483. 41 indexed citations
7.
Sirica, Alphonse E., John M. Venditti, & I Kline. (1971). Enhanced survival response of l1210 leukemic mice to a single combin- ation treatment with cis-platinum(ii) diamminodichloride (cis-pt ii. Nsc-119875) plus cyclophosphamide (cy, nsc-26271). Abstr.. IEEE Transactions on Neural Networks and Learning Systems. PP. 4. 5 indexed citations
8.
Woodman, Richard, John M. Venditti, Saul A. Schepartz, & I Kline. (1971). Icrf-159 (1,2-bis(3,5-dioxopiperazin-1-yl)propane) (nsc-129943). Activity against intracerebrally inoculated l1210, therapeutic superiority against ip l1210 in combination with cis-platinum (ii) diamminodichloride (cis-pt-ii. Nsc-119875). Abstr.. 24. 2 indexed citations
9.
Kline, I, et al.. (1969). Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.. PubMed. 53(5). 265–71. 2 indexed citations
10.
Hoffman, Greg, et al.. (1969). Adaptation of a colorimetric determination of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (NSC-45388) and 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) to blood.. PubMed. 53(3). 199–202. 1 indexed citations
11.
Kline, I, et al.. (1968). Duration of Drug Levels in Mice as Indicated by Residual Antileukemic Efficacy. Chemotherapy. 13(1). 28–41. 26 indexed citations
12.
Abraham, David, Paul P. Carbone, John M. Venditti, I Kline, & Abraham Goldin. (1967). Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice. Biochemical Pharmacology. 16(4). 665–673. 10 indexed citations
13.
Kline, I & R. J. Trapani. (1964). The freezing and preservation of animal tumors. Cryobiology. 1(2). 130–139. 9 indexed citations
14.
Goldin, A, et al.. (1961). Comparison of the effectiveness of Tetramin and its components against advanced leukemia L1210 in mice.. PubMed. 11. 73–6. 1 indexed citations
15.
Venditti, John M., Anthony W. Schrecker, J. A. R. Mead, I Kline, & Abraham Goldin. (1960). Influence of the route of administration on the relative effectiveness of 3',5'-dichloroamethopterin and amethopterin against advanced leukemia (L1210) in mice.. PubMed. 20. 1451–6. 6 indexed citations
16.
Kline, I, et al.. (1960). The effects of chemical agents on cells propagated in tissue culture systems.. PubMed. 9. 73–7. 1 indexed citations
17.
Kline, I, et al.. (1957). Some observations on the response of four established human cell strains to hydrocortisone in tissue culture.. PubMed. 17(8). 780–4. 26 indexed citations
18.
Leighton, Joseph, et al.. (1957). Effects of a podophyllotoxin derivative on tissue culture systems in which human cancer invades normal tissue.. PubMed. 17(4). 336–44. 7 indexed citations
19.
Leighton, Joseph & I Kline. (1954). Studies on human cancer using sponge matrix tissue culture. II. Invasion of connective tissue by carcinoma (strain HeLa).. PubMed. 12(4). 865–73. 12 indexed citations
20.
Leiter, Joseph, J. L. Hartwell, I Kline, Moreshwar V. Nadkarni, & M. J. Shear. (1952). Damage Induced in Sarcoma 37 with Chemical Agents. IV. Derivatives of Colchiceinamide. JNCI Journal of the National Cancer Institute. 13(3). 731–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026